首页
订购/客服:400-666-5481

ARV-110

    
10mM in DMSO

ARV-110

源叶(MedMol)
T97135 一键复制产品信息
2222112-77-6
C41H43ClFN9O6
812.29
3-​Pyridazinecarboxamid​e,N-​[trans-​4-​(3-​chloro-​4-​cyanophenoxy)​cyclohexyl]​-​6-​[4-​[[4-​[2-​(2,​6-​dioxo-​3-​piperidinyl)​-​6-​fluoro-​2,​3-​dihydro-​1,​3-​dioxo-​1H-​isoindol-​5-​yl]​-​1-​piperazinyl]​methyl]​-​1-​piperidinyl]​-
货号 规格 价格 上海 北京 珠海 重庆 武汉 购买数量
T97135-1ml
10mM in DMSO

¥556.00

6 - - - -
产品介绍 参考文献 质检证书(COA) 摩尔浓度计算器 相关产品
产品描述: 雄激素受体抑制剂;Androgen Receptor Inhibitors;;InformationARV-110 ARV-110 is an orally bioavailable, specific androgen receptor (AR) PROTAC degrader that leads to ubiquitination and degradation of AR. ARV-110 completely degrades androgen receptor (AR) in all cell lines tested with DC50 of < 1 nM. ARV-110 can be used for the research of prostate cancer.TargetsAR (Cell-free assay) 1 nM(DC50)
体内研究: Bavdegalutamide (oral gavage; 1 mg/kg; QD) exhibits a greater than 90% AR degradation in vivo. In LNCaP, VCaP and prostate cancer patient derived xenograft (PDX) models, Bavdegalutamide also exhibits significant inhibition of tumor growth and AR signaling.
Bavdegalutamide (oral gavage; 3 or 10 mpk; 30 days) demonstrates in vivo efficacy and reduction of AR-target gene expression in a long term, castrate, enzalutamide-resistant VCaP tumor model. The TGI are 70% and 60% for 3 mpk and 10 mpk dosage. Respectively.
保存条件: -80℃(运输条件:冰袋低温运输)
配置溶液浓度参考:
1mg 5mg 10mg
1 mM 1.231 ml 6.155 ml 12.311 ml
5 mM 0.246 ml 1.231 ml 2.462 ml
10 mM 0.123 ml 0.616 ml 1.231 ml
50 mM 0.025 ml 0.123 ml 0.246 ml
注意: 部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。

参考文献

质检证书(COA)

如何获取质检证书(COA)?
请输入货号和一个与之匹配的批号。
例如:
批号:JS298415 货号:S20001-25g
在货品标签上如何找到货号和批号?

摩尔浓度计算器

质量 (mg) = 浓度 (mM) x 体积 (mL) x 分子摩尔量 (g/mol)

=
×
×